Information on New Approvals and Medication Safety
Search results for: cardiovascular risk
Drug Updates
Information on New Approvals and Medication Safety
Vasculitis
A New perspective on when and how it begins
Reading Rheum
Handpicked Reviews of Contemporary Literature
The RA Body Connection
Novel research explores a possible link between BMI and RA
Osteoarthritis Quo Vadis
Our knowledge of OA has progressed far—does a cure lie ahead?
NSAIDs: The Heart of the Controversy
Rheumatologists on the AHA statement and how to balance NSAID risks and benefits
A Heart In Danger
Rheumatologists should monitor and aggressively treat cardiac risk factors in patients with lupus and rheumatoid arthritis
Exploring the Role of Neutrophil Extracellular Traps in Systemic Lupus Erythematosus
An understanding of the mechanisms underlying NET-mediated inflammation will empower clinicians to target therapies that can mitigate disease activity & improve outcomes in patients with lupus.
15,000 Patient-Years: Safety Data for Upadacitinib Treatment Across Multiple Rheumatic Conditions
Burmester et al. characterized the long-term safety profile of upadacitinib treatment across multiple rheumatic diseases.
- « Previous Page
- 1
- …
- 19
- 20
- 21
- 22
- 23
- …
- 56
- Next Page »